|
|
¼¿Æ®¸®¿ÂÇコÄɾî, Á÷Á¢ ÆǸŷΠÀüȯÇÒ Àû±â |
±è»ç¶û ±âÀÚ |
2022-11-25 10:55 |
»ï¼º¹ÙÀÌ¿À·ÎÁ÷½º, CDMO ¾ÈÁ¤Àû ¼ºÀå°ú ¹ÙÀÌ¿À½Ã¹Ð·¯ ½ÃÀåÈ®´ë |
¹Úº´¿ì ±âÀÚ |
2022-11-25 10:51 |
HKÀ̳뿣, ÄÉÀÌĸ, ±Û·Î¹ú ÁøÃâÀº 23³â¿¡µµ |
±è»ç¶û ±âÀÚ |
2022-11-25 10:47 |
Á¦¾à/¹ÙÀÌ¿À 2023³â Àü¸Á, The Threshold of Growth |
¹Úº´¿ì ±âÀÚ |
2022-11-24 11:04 |
ÀÎÅÍ·ÎÁ¶, À۳⵵, ¿ÃÇصµ, ³»³âµµ »ç»ó ÃÖ´ë ½ÇÀû Àü¸Á |
¹Úº´¿ì ±âÀÚ |
2022-11-22 16:33 |
¶óÀÎ |
Á¦¾à/¹ÙÀÌ¿À Weekly-ÇÑÈÅõÀÚÁõ±Ç |
¹Úº´¿ì ±âÀÚ |
2022-11-22 08:06 |
ȯÀÎÁ¦¾à,ÅõÀÚ¿¡µµ ºÒ±¸ÇÏ°í ³ôÀº ¾ÈÁ¤¼ºÀ» º¸À¯ÇÑ ¾ËÂ¥±â¾÷ |
¹Úº´¿ì ±âÀÚ |
2022-11-22 08:02 |
Á¦¾à¹ÙÀÌ¿À ½Å»ç¾÷ Àüȯ ¹× Àü·« -M&A¸¦ ÅëÇÑ ¹ÙÀÌ¿À ÁøÃâ |
¹Úº´¿ì ±âÀÚ |
2022-11-18 11:22 |
¹ÙÀÌÁ¨¼¿, Â÷¼¼´ë ¸é¿ªÇ׾ϡ¤¸é¿ª¾ïÁ¦ ¼¼Æ÷Ä¡·áÁ¦ Àü¹®±â¾÷ |
±è»ç¶û ±âÀÚ |
2022-11-18 10:13 |
µ¿±¹Á¦¾à, 3Q22 Review: YoY ȸº¹Àº ÀÖ¾úÁö¸¸.. |
±è»ç¶û ±âÀÚ |
2022-11-16 13:42 |
¶óÀÎ |
´ë¿øÁ¦¾à, 3ºÐ±â¸¸¿¡ 2021³â ¸ÅÃâÀ» ÃÊ°ú´Þ¼º |
¹Úº´¿ì ±âÀÚ |
2022-11-16 13:37 |
¿À½ºÅÛÀÓÇöõÆ®, ¾Æ½Ã¾Æ ÃÖ°í¿¡¼ ±Û·Î¹ú ÃÖ°í¸¦ ÇâÇØ |
¹Úº´¿ì ±âÀÚ |
2022-11-16 07:48 |
Á¦¾à/¹ÙÀÌ¿À Weekly-ÇÑÈÅõÀÚÁõ±Ç |
¹Úº´¿ì ±âÀÚ |
2022-11-14 16:50 |
Çѱ¹Äݸ¶, ¿¹»ó ¹üÀ§ ³»ÀÇ 3ºÐ±â ºÎÁø, ±â´ëµÇ´Â ±× ÀÌÈÄ |
±è»ç¶û ±âÀÚ |
2022-11-14 16:21 |
¾¾Á¨, ÀÏȸ¼º ºñ¿ëÀ¸·Î ÀÎÇÑ ¾î´× ¼îÅ© |
¹Úº´¿ì ±âÀÚ |
2022-11-14 16:16 |
¶óÀÎ |
JWÁß¿ÜÁ¦¾à, 3Q22 Review: Àúµµ ´ä´äÇÏÁö¸¸ ¿¬°£À¸·Î º¾´Ï´Ù |
¹Úº´¿ì ±âÀÚ |
2022-11-11 15:03 |
Biosimilar Industry Update: ÁÖ¿ä ±â¾÷ 3ºÐ±â ½ÇÀû update |
±è»ç¶û ±âÀÚ |
2022-11-11 09:31 |
¼¿Æ®¸®¿Â, ¹ÙÀÌ¿À½Ã¹Ð·¯ Áß½ÉÀÇ ¼ºÀåÀ» ½ÃÇöÇÑ 3ºÐ±â |
±è»ç¶û ±âÀÚ |
2022-11-10 15:50 |
°½ºÅÛ¹ÙÀÌ¿ÀÅØ, Á¦´ëÇ÷ À¯·¡ Áٱ⼼Æ÷Ä¡·áÁ¦ Àü¹®±â¾÷ |
¹Úº´¿ì ±âÀÚ |
2022-11-10 08:01 |
ÆĹ̼¿, ¶°¿À¸£´Â »ûº° |
¹Úº´¿ì ±âÀÚ |
2022-11-09 07:54 |
|